Back to News
Market Impact: 0.12
法院批准的法律通知,州总检察长仿制处方药和解,分配与发放计划通知
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
Several generic prescription drug manufacturers reached settlements in three lawsuits brought by state attorneys general, which alleged that purchasers, including consumers, paid artificially inflated prices. The states proposed a plan to distribute consumer compensation funds to eligible consumers who submit claims on time; the notice covers qualifying purchases made in the U.S. from May 1, 2009, through December 31, 2019.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Crushed tech stocks bounce — plus, new doctor survey keeps us positive on Lilly
- Capital One, General Motors are among the stocks reporting this week with momentum. Here are the others
- Amazon to fund 12 small nuclear reactors at former Indiana coal plant
- Merck KGaA to acquire Silence Therapeutics for $1.3 billion
- Disc Medicine surges 38% after bitopertin clears Phase 3 trial endpoints
- Silence Therapeutics jumps 59% on Merck takeover